Carl Dambkowski

Carl Dambkowski

Director Técnico/Científico/I+D en APOGEE THERAPEUTICS, INC. .

Fortuna: 26 M $ al 31/07/2026

41 años
Health Technology
Consumer Services
Commercial Services

Perfil

Carl Dambkowski is the founder of Novonate, Inc., founded in 2015.
Current jobs include Independent Director at Oruka Therapeutics, Inc. since 2024 and Chief Medical Officer at Apogee Therapeutics, Inc. since 2022.
Former jobs include Chief Medical Officer at QED Therapeutics, Inc. from 2021 to 2022, Chief Strategy Officer & EVP-Operations at Origin Biosciences, Inc. from 2018 to 2021, Chief Medical Officer at Navire Pharma, Inc. from 2020 to 2022, and Associate at McKinsey & Co., Inc. from 2016 to 2018.
Education includes graduate studies at The Trustees of Columbia University in The City of New York and undergraduate and doctorate degrees from Stanford University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
05/08/2026 168.498 ( 0,3 % ) 23 M $ 31/07/2026
0,06 %
12/06/2026 38.743 ( 0,06 % ) 4 M $ 31/07/2026

Cargos activos de Carl Dambkowski

EmpresasCargoInicio
APOGEE THERAPEUTICS, INC. Director Técnico/Científico/I+D 01/09/2022

Antiguos cargos conocidos de Carl Dambkowski.

EmpresasCargoFin
Director Técnico/Científico/I+D 01/09/2022
Director Técnico/Científico/I+D 01/09/2022
Corporate Officer/Principal 01/06/2021
Corporate Officer/Principal 01/03/2018
Fundador -
Ver el detalle de la experiencia de Carl Dambkowski.

Formación de Carl Dambkowski.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

73

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas8

Commercial Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology